Crossmark

The recommendations of Chinese Parkinson’s disease and movement disorder society consensus on therapeutic management of Parkinson’s disease

Crossref DOI link: https://doi.org/10.1186/s40035-016-0059-z

Published Online: 2016-06-30

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Shengdi

Chan, Piu

Sun, Shenggang

Chen, Haibo

Zhang, Baorong

Le, Weidong

Liu, Chunfeng

Peng, Guoguang

Tang, Beisha

Wang, Lijuan

Cheng, Yan

Shao, Ming

Liu, Zhenguo

Wang, Zhenfu

Chen, Xiaochun

Wang, Mingwei

Wan, Xinhua

Shang, Huifang

Liu, Yiming

Xu, Pingyi

Wang, Jian

Feng, Tao

Chen, Xianwen

Hu, Xingyue

Xie, Anmu

Xiao, Qin
Funding

Funding for this research was provided by:

Natural Science Fund of China (81430022)

National Key Basic Research Program of China (2006cb500706, 2011CB504104)

Shanghai Science and Technology Fund (10411954500)